A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients
- PMID: 16391541
- DOI: 10.1038/sj.ijir.3901427
A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients
Abstract
Erectile dysfunction (ED) is increasingly considered as one manifestation of systemic vascular disease. Accordingly, ED and coronary artery disease share mutual risk factors and frequently coexist. Sexual health is an important aspect of our patients' lives, and ED is a common concern of the cardiovascular patient. Despite this, sexual function is under-addressed in the cardiac patient. Even when this topic is broached by the primary care physician or urologist, ED frequently remains untreated due to safety concerns involving cardiac disease and other comorbidities. This article describes our experience with this unique patient population, as well as our approach to building a multidisciplinary clinic designed to specifically address the important issue of ED in the cardiac patient.
Similar articles
-
[The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].Przegl Lek. 2009;66(4):192-7. Przegl Lek. 2009. PMID: 19708509 Review. Polish.
-
Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.Curr Med Res Opin. 2007 Dec;23(12):3189-98. doi: 10.1185/030079907X242656. Curr Med Res Opin. 2007. PMID: 17991309 Review.
-
Prevention of cardiovascular disease by the early identification of erectile dysfunction.Int J Impot Res. 2008 Dec;20 Suppl 2:S9-14. doi: 10.1038/ijir.2008.47. Int J Impot Res. 2008. PMID: 19002117 Review.
-
Erectile dysfunction and cardiovascular disease.Postgrad Med. 2011 May;123(3):7-16. doi: 10.3810/pgm.2011.05.2279. Postgrad Med. 2011. PMID: 21566411 Review.
-
[Erectile dysfunction and cardiovascular disease].Acta Med Croatica. 2006;60(1):51-3. Acta Med Croatica. 2006. PMID: 16802572 Review. Croatian.
Cited by
-
β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality.Rev Cardiovasc Med. 2022 May 13;23(5):173. doi: 10.31083/j.rcm2305173. eCollection 2022 May. Rev Cardiovasc Med. 2022. PMID: 39077590 Free PMC article. Review.
-
Superoxide dismutase analog (Tempol: 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine 1-oxyl) treatment restores erectile function in diabetes-induced impotence.Int J Impot Res. 2009 Nov-Dec;21(6):348-55. doi: 10.1038/ijir.2009.28. Epub 2009 Jun 25. Int J Impot Res. 2009. PMID: 19554009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical